Navigation Links
MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R)
Date:8/26/2009

ocet(R), which contains an opioid (oxycodone) combined with acetaminophen (like Tylenol(R)) have been the subject of recent FDA scrutiny due to their potential for causing significant adverse effects on liver and gastrointestinal function.

To date, more than 400 patients in six clinical trials have received MoxDuo IR for different forms of post-surgical pain (bunionectomy and total knee replacement). Study results with MoxDuo(TM) IR consistently demonstrate fewer side effects than observed with morphine alone, oxycodone alone and now with Percocet(R).

In this open label trial, each group of patients who experienced moderate to severe post-operative pain following total knee replacement surgery were treated every four to six hours over a 48-hour period. The study enrolled a total of 44 patients at five US clinical research sites.

All primary study objectives were met comparing: (1) the analgesic efficacy and safety profile of MoxDuo(TM) IR against control groups of patients receiving Percocet(R), a frequently used opioid for the treatment of pain; and (2) a flexible dosing regimen of MoxDuo(TM) IR against a fixed low dose (3/2mg). Patients receiving the flexible dosing regimen of MoxDuo(TM) IR achieved significantly greater pain relief than those receiving the low dose formulation (p<0.05).

Data collected from this study provide additional guidance for optimising the design and implementation of pending pivotal Phase 3 studies as the Company prepares for New Drug Application (NDA) filings with the US Food and Drug Administration (FDA) in 2010.

MoxDuo(TM) IR, the Company's lead product candidate, is part of a larger Dual-Opioid portfolio including intravenous (MoxDuo(TM) IV) and controlled release (MoxDuo(TM) CR) formulations. These formulations are designed to incorporate tamper resistance and reduced abuse liability as appropriate.

Dr. Br
'/>"/>

SOURCE QRxPharma Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients
2. Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class
3. Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
4. Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
5. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
6. Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
7. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
8. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
9. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
10. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
11. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 The Parenteral Drug ... has finalized agreement with Richard M. Johnson ... "We are very pleased to have Richard ... Hal Baseman , the Chair of the Board ... performance and growth.  Richard has led a strong staff ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ... of the "Global Suture Industry Report 2015" ... Global Suture Industry Report 2015 is a professional ... the suture industry. The report provides ... classifications, applications and industry chain structure. The suture ...
(Date:5/6/2015)... South Africa , May 6, 2015 /PRNewswire/ ... people than HIV/AIDS, malaria and tuberculosis combined[1]. Approximately 40 percent ... be cured with the right treatment[3]. Together with Elekta, ministries ... to build up their radiation therapy infrastructures and save lives. ... worldwide would benefit from radiation therapy[4] during the course of ...
Breaking Medicine Technology:PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2Global Suture Industry Report 2015 - Forecast Trends to 2021 2Global Suture Industry Report 2015 - Forecast Trends to 2021 3Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4
... 9, 2012  Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ... diseases associated with inflammation, will release its fourth quarter ... February 21, 2012. Anthera will host a conference call ... release. The Company will also provide an update for ...
... Texas, Feb. 9, 2012   SmallCapVoice.com, Inc. announced ... PositiveID Corporation (OTCBB: PSID.OB), a developer of ... available. The interview can be heard at ... a recognized corporate investor relations firm, with ...
Cached Medicine Technology:Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call 2A New Audio Interview with PositiveID Chairman and CEO, William J. Caragol, is now at SmallCapVoice.com 2
(Date:5/6/2015)... HOUSTON, TX (PRWEB) May 06, 2015 ... the 1,000 user mark after launching in mid-February. The ... qualified candidates who have previous experience in the industry. ... their profession. , According to Kyle Johnson, CTO, unique ... compared to the first month: "Each new job posting ...
(Date:5/6/2015)... Locally owned, Greek olive oil producer and importer, Our ... having one the best Extra Virgin Olive Oils in the ... of Greece and known as Laconiko , received the ... Olive Oil, which is defined by the competition as “the ... producer applicants from 25 different countries applying, Laconiko stood out ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Dr. Vito C. ... plastic surgeons , recently completed a medical mission trip to ... on those affected by microtia and other deformities of ... April 17 and ended on April 26, Dr. Quatela and ... Microtia is a congenital deformity where the outside of the ...
(Date:5/6/2015)... Angeles, California (PRWEB) May 06, 2015 ... secured its first round of VC funding and launched ... , The enterprise class embeddable software enables applications to ... data as it moves between systems and locations. Available ... HyperTransfer technology moves files at line speed, independent of ...
(Date:5/6/2015)... Cloud security companies Sookasa Inc . ... to help small-to-medium businesses secure their sensitive data more ... teaming up to transition SafeMonk customers to Sookasa’s feature-rich ... welcome SafeMonk users to the Sookasa family, and it’s ... the global powerhouse SafeNet (now Gemalto IDSS), are giving ...
Breaking Medicine News(10 mins):Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 4Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3
... Facing State, LOS ANGELES, April 1, 2008 ... statewide forums on,Thursday, in which experts in the field ... potential solutions., The 2008 Quality Care Forum will ... the wide disparities in quality of care,delivered at different ...
... reduction in Meth use, PALTO ALTO, Calif., ... its new advertising campaign, including a series of,television ... the Oscar-nominated director and producer whose works,include "Babel," ... launched,today in Montana, are designed to communicate the ...
... April 1, 2008 ISTA,Pharmaceuticals, Inc. (Nasdaq: ... Company as its financial advisor. For more than ... and financial sponsors regarding,new product opportunities and potential ... the scale of ISTA,s business. In addition, ISTA ...
... principles of Consumer-Purchaser Disclosure,Project, include review of ... 1, 2008 Today URAC called,for public ... and Health Network,accreditation program standards. URAC is ... policy makers, consumers, health care,management organizations and ...
... or badly injured every six seconds, experts say , , TUESDAY, ... each year on the world,s roadways -- more than are ... In response to this growing epidemic, the United Nations, General ... safety, to be held next year in Russia. , It,s ...
... Senator Tom Harkin, Sheila,Johnson, and Dr. Elliott Sigal, ... and,CNN Anchor and Special Correspondent Soledad O,Brien, WASHINGTON, ... will hold its Fifth Annual Awards Gala on,Wednesday, May ... DC.,The honorees are U.S. Senator Tom Harkin (D-IA), Sheila ...
Cached Medicine News:Health News:Oscar-Nominated Filmmaker Alejandro Gonzalez Inarritu Directs New Meth Project Advertising Campaign 2Health News:Oscar-Nominated Filmmaker Alejandro Gonzalez Inarritu Directs New Meth Project Advertising Campaign 3Health News:Oscar-Nominated Filmmaker Alejandro Gonzalez Inarritu Directs New Meth Project Advertising Campaign 4Health News:ISTA Pharmaceuticals Engages Cowen as Financial Advisor 2Health News:ISTA Pharmaceuticals Engages Cowen as Financial Advisor 3Health News:URAC Invites Public Input in Response to Revisions to Health Plan and Health Network Accreditation Programs 2Health News:U.N. Seeks to Curb World's Traffic Deaths 2Health News:U.N. Seeks to Curb World's Traffic Deaths 3Health News:U.N. Seeks to Curb World's Traffic Deaths 4Health News:Honorees for National Lupus Awards Announced 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: